neurological care News
-
Zeto Raises Series A Funding to Accelerate Commercialization Efforts of its Easy Use Electroencephalography (EEG) Headset and Software Platform
Zeto, Inc., a privately held medical technology company that is transforming the Electroencephalography (EEG) experience for healthcare, today announced that it has raised $7.3 million in Series A financing led by Seraph Group and joined by Aphelion Capital, SV Tech Ventures and Shangbay Capital. Zeto raised $4 million previously in dilutive and non-dilutive funding. The new capital will be used ...
By Zeto, Inc.
-
People with Parkinson’s Disease may have double the risk for Melanoma, a dangerous skin cancer
An analysis of several studies shows that people with Parkinson’s disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases. The research is published in the June 7, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. Parkinson’s disease is a brain disorder ...
-
People with Parkinson’s disease may have double the risk for melanoma, a dangerous skin cancer
An analysis of several studies shows that people with Parkinson’s disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases. The research is published in the June 7, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. Parkinson’s disease is a brain disorder ...
-
LOK Corporation and Sense Neuro Diagnostics Announce Commercial Partnership Focused on International Market
(August 17, 2021—Montreal, Canada and Cincinnati, Ohio) LOK Corporation, a manufacturing agent that helps companies develop and manage their international distribution network and Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients today announced a commercial partnership to bring innovative brain scanners being developed ...
-
Sense announces strategic collaboration with healthcare catalyst Inflect Health
Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, today announced a strategic collaboration with Inflect Health, the new nationwide, multispecialty investment and innovation hub formed by Vituity. As part of this new relationship, Inflect Health will provide Sense access to its robust network of frontline physicians and ...
-
Faster & Better EEG Tests with Zeto Health Technology Podcast with Aswin Gunasekar, CEO & Founder, Zeto
For the August installment of the Healthtech Leader of the Month series, we interviewed Aswin Gunasekar, founder and CEO of Zeto. Zeto is a device-driven platform for acquiring, accessing, and interpreting electroencephalograms (EEGs). An EEG is a test used to evaluate electrical activity in the ...
By Zeto, Inc.
-
Mission Based Media Launches Alzheimer`s Podcast, the Newest Podcast Miniseries on Health Unmuted
Mission Based Media, a leader in podcasts about health, care and well-being, has launched a new podcast miniseries about Alzheimer's disease. The Alzheimer's Podcast miniseries provides insights and information for those who are diagnosed with Alzheimer's disease and the people who care about them. The miniseries was created with support from Altoida, a leading platform to improve drug ...
-
Public attitudes towards end-of-life care in progressive neurological illness are conflicted, study reveals
Public attitudes in UK and USA reveal support both for life-sustaining interventions and for measures to enable peaceful death in progressive neurological illness such as dementia, according to a survey carried out by researchers at the University of Cambridge. The study found that one in six people believes that measures must be taken to sustain life at any cost even when a patient is in the ...
-
Methodist University Hospital Is First In The World To Participate In Groundbreaking EEG Study For Inpatients That Improves Brain Monitoring During the COVID-19 Crisis
Methodist Le Bonheur Healthcare (MLH) is the first hospital system globally to participate in a landmark study using a first-of-its-kind EEG device. EEG stands for electroencephalogram. EEG tests are conducted to detect problems in the brain that may be associated with certain brain disorders such as seizures, tumors or strokes. A typical EEG test consists of multiple electrodes attached to a ...
By Zeto, Inc.
-
Diffusion Pharmaceuticals Announces Clearance of IND Application for TSC by FDA’s Pulmonology, Allergy, and Critical Care Division
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (Diffusion or the Company), an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced that the Company has obtained clearance of its Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration’s ...
By CervoMed
-
GE Researches dedicated MRI Brain Scanner Technology
Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of ...
By GE Power
-
Altoida Appoints Neuroscience Pioneer Dr. Antontella Santuccione Chadha as Chief Medical Officer
Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced the appointment of Dr. Antonella Santuccione Chadha as Chief Medical Officer. In this new role, Dr. Chadha will lead all clinical and medical affairs as the company continues to develop, validate, and commercialize ...
-
Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform
Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that it has successfully raised an additional $14 million for its Series A round with new and existing investors. The investment was co-led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you